Pra (PRAA) EBIT Growth (1y) (2010 - 2026)
Powered by 
Analysis
Pra (PRAA) EBIT Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn | - |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - | -36.55% |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn | 97.36% |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn | 81.81% |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | - |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn | - |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - | -6.01% |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - | -338.10% |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn | 6.95% |
| 10 | Pra | 790.61 Mn | 725.61 Mn | 356.41 Mn | 80.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.10% |
| Mar 31, 2026 | 38.45% |
| Dec 31, 2025 | 33.41% |
| Sep 30, 2025 | -450.69% |
| Jun 30, 2025 | -4.61% |
| Mar 31, 2025 | 12.32% |
| Dec 31, 2024 | 106.76% |
| Sep 30, 2024 | 109.03% |
| Jun 30, 2024 | 95.83% |
| Mar 31, 2024 | 297.35% |
| Dec 31, 2023 | -23.24% |
| Sep 30, 2023 | -39.19% |
| Jun 30, 2023 | -45.59% |
| Mar 31, 2023 | -146.75% |
| Dec 31, 2022 | -28.06% |
| Sep 30, 2022 | -8.75% |
| Jun 30, 2022 | -19.65% |
| Mar 31, 2022 | -35.02% |
| Dec 31, 2021 | -7.58% |
| Sep 30, 2021 | -12.50% |